Full Text (PDF)
Case Report

The Role of Plasmapheresis in Amlodipine Overdose

Tejasvi C, C. Preethi Goutham

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Anesthesia and Analgesia 11(3):p 139-141, July- September 2024. | DOI: 10.21088/ijaa.2349.8471.11324.4

How Cite This Article:

Tejasvi C, Goutham CP. The role of plasmapheresis in amlodipine overdose. Ind J Anesth Analg. 2024;11(3):139-41.

Timeline

Received : March 20, 2024         Accepted : May 28, 2024          Published : September 28, 2024

Abstract

Amlodipine overdose is scarcely reported from India, though rare but associated with high mortality. It can lead profound refractory hypotension and shock leading to end organ damage. Management involves early and aggressive measures and calcium in large doses to overcome competitive blockade, hyperinsulinemiaeugycemic therapy, along with some rescue therapies tried in anectodal reports. We report one such case of amlodipine overdose and was successfully managed.


References

  • 1.   DeWitt CR, Walksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and B-blocker toxicity. Toxicol Rev 2004;23:223-38.
  • 2.   Tapan Patel, MD, David Tietze, MD, Amlodipine overdose.Proc (BaylUniv Med Cent). 2013 Oct; 26(4): 410–411.
  • 3.   Kenny J. Treating overdose with calcium channel blockers. BMJ. 1994;308:992–3. [PMC free article] [PubMed] [Google Scholar].
  • 4.   Saravu K, Balasubramanian R. Near-Fatal Amlodipine poisoning. J Assoc Physicians India. 2004;52:156–7. [PubMed] [Google Scholar].
  • 5.   Russel RP. Side effects of calcium channel blockers. Hypertension. 1988;13:I37–40. [Google Scholar].
  • 6.   Yuan TH, Kerns WP, II, Tomaszewski CA, Ford MD, Klinc JA. Insulin glucose as adjunctive therapy for severe calcium channel antagonist poisoning. ClinToxicol. 1999;37:463–74. [PubMed] [Google Scholar].
  • 7.   Boyer EW, Shannon M. Treatment of calcium channel blocker intoxication with insulin infusion. N Engl J Med. 2001;344:1721–2. [PubMed] [Google Scholar].
  • 8.   Kute VB, Shah PR, Goplani KR, Gumber MR, Vanikar AV, Trivedi HL. Successful treatment of refractory hypotension, noncardiogenic pulmonary edema and acute kidney injury after an overdose of amlodipine. Indian J Crit Care Med. 2011;15:182–4 [PMC free article] [PubMed] [Google Scholar].
  • 9.   Lheureux PE, Zahir S, Gris M, Derrey AS, Penaloza A. Bench-to-bedside review: hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers. Crit Care. 2006;10(3):212. [PMC free article] [PubMed] [Google Scholar].
  • 10.   Azendour H, Belyamani L, Atmani M, Balkhi H, Haimeur C. Severe amlodipine intoxication treated by hyperinsulinemia euglycemia therapy. J Emerg Med. 2010;38(1):33–35. [PubMed] [Google Scholar].
  • 11.   Schwartz J, Padmanabhan A, Aqui N et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the seventh special issue. J ClinApher. 2016;31:149-162.

Data Sharing Statement

There are no additional data available.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

Information not provided.

Conflicts of Interest

The authors report no conflicts of interest in this work.


About this article


Cite this article

Tejasvi C, Goutham CP. The role of plasmapheresis in amlodipine overdose. Ind J Anesth Analg. 2024;11(3):139-41.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
March 20, 2024 May 28, 2024 September 28, 2024

DOI: 10.21088/ijaa.2349.8471.11324.4

Keywords

Amlodipinecalcium channel blockerHypotensionPlasmapheresis

Article Level Metrics

Last Updated

Saturday 07 February 2026, 19:24:43 (IST)


1189

Accesses

6
194
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received March 20, 2024
Accepted May 28, 2024
Published September 28, 2024

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share